MA53178A - Dinucléotides cycliques en tant qu'agonistes sting - Google Patents

Dinucléotides cycliques en tant qu'agonistes sting

Info

Publication number
MA53178A
MA53178A MA053178A MA53178A MA53178A MA 53178 A MA53178 A MA 53178A MA 053178 A MA053178 A MA 053178A MA 53178 A MA53178 A MA 53178A MA 53178 A MA53178 A MA 53178A
Authority
MA
Morocco
Prior art keywords
sting agonists
cyclic dinucleotides
dinucleotides
cyclic
sting
Prior art date
Application number
MA053178A
Other languages
English (en)
Inventor
Leonid Beigelman
Gilles Bignan
Peter J Connolly
James P Edwards
Stuart Emanuel
Mark Richter
Wim Bert Griet Schepens
Santhosh Kumar Thatikonda
Johannes Wilhelmus J F Thuring
Marcel Viellevoye
Guangyi Wang
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of MA53178A publication Critical patent/MA53178A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA053178A 2018-07-17 2019-07-16 Dinucléotides cycliques en tant qu'agonistes sting MA53178A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862699001P 2018-07-17 2018-07-17

Publications (1)

Publication Number Publication Date
MA53178A true MA53178A (fr) 2021-05-26

Family

ID=67999987

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053178A MA53178A (fr) 2018-07-17 2019-07-16 Dinucléotides cycliques en tant qu'agonistes sting

Country Status (21)

Country Link
US (2) US11597746B2 (fr)
EP (1) EP3823976A1 (fr)
JP (1) JP2021531277A (fr)
KR (1) KR20210033026A (fr)
CN (1) CN112424212A (fr)
AR (1) AR122240A1 (fr)
AU (1) AU2019304230B2 (fr)
BR (1) BR112021000693A2 (fr)
CA (1) CA3106602A1 (fr)
EA (1) EA202190298A1 (fr)
EC (1) ECSP21003171A (fr)
IL (1) IL280105A (fr)
JO (1) JOP20190179A1 (fr)
MA (1) MA53178A (fr)
MX (1) MX2021000625A (fr)
PE (1) PE20211636A1 (fr)
PH (1) PH12020552172A1 (fr)
SG (1) SG11202012624RA (fr)
TW (1) TW202030199A (fr)
UY (1) UY38304A (fr)
WO (1) WO2020016782A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3724205B1 (fr) * 2017-12-15 2022-06-22 Janssen Biotech, Inc. Dinucléotides cycliques utilisés en tant qu'agonistes de sting
TW202030199A (zh) * 2018-07-17 2020-08-16 美商健生生物科技公司 作為ｓｔｉｎｇ促效劑之環狀二核苷酸
WO2021206158A1 (fr) 2020-04-10 2021-10-14 小野薬品工業株式会社 Méthode de cancérothérapie
WO2024226872A2 (fr) * 2023-04-26 2024-10-31 Lakewood Amedex, Inc. Composés hétérocycliques bicycliques substitués, compositions et leurs utilisations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6411676B2 (ja) * 2015-12-03 2018-10-24 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ Ｓｔｉｎｇの調節因子としての環状プリンジヌクレオチド
WO2017123657A1 (fr) * 2016-01-11 2017-07-20 Gary Glick Dinucléotides cycliques pour traiter des affections associées à l'activité sting comme le cancer
HUE073018T2 (hu) * 2016-01-11 2026-01-28 Innate Tumor Immunity Inc Ciklikus dinukleotidok állapotok kezelésére, amelyek STING-aktivitással kapcsolatosak, mint például rák
CN114751950B (zh) * 2016-03-18 2025-04-18 免疫传感器公司 环二核苷酸化合物及使用方法
KR102569881B1 (ko) * 2016-07-06 2023-08-22 에프-스타 테라퓨틱스 인코포레이티드 질병 치료용 화합물, 조성물 및 방법
WO2018045204A1 (fr) * 2016-08-31 2018-03-08 Ifm Therapeutics, Inc Analogues de dinucléotides cycliques pour traiter des états associés à l'activité de la piqûre (stimulateur des gènes de l'interféron)
JOP20170188A1 (ar) * 2016-11-25 2019-01-30 Janssen Biotech Inc ثنائي النوكليوتيدات الحلقية كمنبهات ستينغ (sting)
TW202030199A (zh) * 2018-07-17 2020-08-16 美商健生生物科技公司 作為ｓｔｉｎｇ促效劑之環狀二核苷酸

Also Published As

Publication number Publication date
SG11202012624RA (en) 2021-02-25
PH12020552172A1 (en) 2021-06-07
IL280105A (en) 2021-03-01
EP3823976A1 (fr) 2021-05-26
US20230287034A1 (en) 2023-09-14
US20210277046A1 (en) 2021-09-09
AR122240A1 (es) 2022-08-31
EA202190298A1 (ru) 2021-04-16
CA3106602A1 (fr) 2020-01-23
UY38304A (es) 2020-01-31
WO2020016782A1 (fr) 2020-01-23
TW202030199A (zh) 2020-08-16
BR112021000693A2 (pt) 2021-04-13
AU2019304230A1 (en) 2021-01-14
AU2019304230B2 (en) 2023-08-31
KR20210033026A (ko) 2021-03-25
JOP20190179A1 (ar) 2020-01-17
CN112424212A (zh) 2021-02-26
US11597746B2 (en) 2023-03-07
PE20211636A1 (es) 2021-08-24
ECSP21003171A (es) 2021-02-26
MX2021000625A (es) 2021-03-25
JP2021531277A (ja) 2021-11-18

Similar Documents

Publication Publication Date Title
EP3621624A4 (fr) Composés dinucléotidiques cycliques en tant qu'agonistes sting
EP3344644A4 (fr) Composés di-nucléotidiques cycliques en tant qu'agonistes de sting
MA52189A (fr) Benzothiophènes et composés associés utilisés en tant qu'agonistes de sting
MA46452A (fr) Composés de benzo[b]thiophéne en tant qu'agonistes de sting
MA54546A (fr) Amides d'hétéroaryle utiles en tant qu'inhibiteurs de kif18a
MA54547A (fr) Amides d'hétéroaryle utiles en tant qu'inhibiteurs de kif18a
EP3755311A4 (fr) Indane-amines utiles en tant qu'antagonistes de pd-l1
DK3512861T3 (da) Cykliske dinukleotider som sting-(stimulator af interferongener)-agonister
MA48994A (fr) Isoquinoléines utilisées en tant qu'inhibiteurs de hpk1
EP3755331A4 (fr) Agonistes de la protéine sting
MA47123A (fr) Dérivés de benzooxazole en tant qu'mmunomodulateurs
MA49566A (fr) Carboxamides utilisés en tant qu'inhibiteurs des canaux sodiques
EP3883570A4 (fr) Hétérocycles fonctionnalisés utiles en tant qu'agents antiviraux
EP3386981A4 (fr) Hétérocycles utiles en tant qu'agents anticancereux
EP3423044A4 (fr) Nanovaccin activant sting pour l'immunothérapie
MA49563A (fr) Anticorps bispécifiques en tant qu'inhibiteurs de points de contrôle
MA47460A (fr) Aminotriazolopyridines utilisées en tant qu'inhibiteurs de kinase
MA42032A (fr) Acides 3-aryl-4-amido-bicyclo [4,5,0]hydroxamiques en tant qu'inhibiteurs de hdac
EP3694867C0 (fr) Dinucléotides cycliques utilisés en tant qu'agents anticancéreux
MA48803A (fr) Cycles 6-5 fusionnés utilisés en tant qu'inhibiteurs de c5a
MA47736A (fr) Pyrimidopyrimidinones utiles en tant qu'inhibiteurs de la kinase wee-1
EP3853365A4 (fr) Modulateurs de l'expression de pnpla3
EP3601569A4 (fr) Modulateurs de l'expression de pcsk9
IL280105A (en) Cyclic dinucleotides as sting agonists
EP3886879A4 (fr) Plaquettes en tant qu'agents de livraison